Community
Our community narratives are driven by numbers and valuation.
Value any stock for free in seconds
Get alerts and valuation updates
Participate in discussions
Weekly Picks
FR
FrugalBull
Community Contributor
Enterprise, AI & Cloud Growth Ahead, Waiting For the Right Price 💸
Catalysts AI Integration (Atlassian Intelligence & Rovo) Atlassian is strongly positioned to leverage AI to increase workforce efficiency, particularly in large enterprises and is actively embedding AI across its product suite. In 2024 it introduced Atlassian Rovo , an AI teammate that uses Atlassian’s “teamwork graph” to help enterprise users find information across their tools and act on insights quickly.
View narrativeUS$204.74
FV
9.5% overvalued intrinsic discount19.00%
Revenue growth p.a.
3users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
1 day ago author updated this narrative
TO
Tokyo
Community Contributor
Good foundation, but now it's all about the next steps
Update from 10.03.2025 Now proftiability is no longer ahead, Todd McKinnon reached profitability! In SWS Overview it is staded: "Became profitable this year" Under 2.1 now you can see the break even to $28M.
View narrativeUS$147.87
FV
27.6% undervalued intrinsic discount18.45%
Revenue growth p.a.
4users have liked this narrative
0users have commented on this narrative
37users have followed this narrative
2 days ago author updated this narrative
DZ
Dzitkowskik
Community Contributor
XTB's Path to 100–120 PLN by 2028 Amid Market Volatility
1. Current Data Snapshot (as of March 6, 2025) XTB is a Warsaw-based brokerage firm specializing in retail and institutional trading of financial instruments, including CFDs, forex, stocks, and ETFs. Here’s what we can infer from available data up to this point: Stock Price Performance: XTB hit an all-time high of 78.00 PLN on January 21, 2025, with a market cap around 7.89 billion PLN (as per TradingView data).
View narrativezł100.96
FV
36.6% undervalued intrinsic discount15.00%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
2 days ago author updated this narrative
DA
DailyInvestors
Community Contributor
The Apples are getting ready to Bloom.
Apple: This Tree is just now getting ready to bloom. Apple or “AAPL” in NASDAQ currently getting ready to come off of a Bearish Signal.
View narrativeUS$309.00
FV
28.5% undervalued intrinsic discount9.69%
Revenue growth p.a.
3users have liked this narrative
0users have commented on this narrative
10users have followed this narrative
1 day ago author updated this narrative
DZ
Dzitkowskik
Community Contributor
Betting on PlayWay's Game Releases Could Push Stock to 400 PLN by 2027
Outlook for the Next Few Years (2025–2027) Bullish Case Catalysts : Successful 2025 game releases (e.g., from Madnetic Games or core franchises like Car Mechanic Simulator) could boost revenue and sentiment, potentially pushing the stock toward 350–400 PLN by 2026, as some users suggest. The gaming industry’s growth, especially in mobile and console markets, could amplify this if PlayWay capitalizes on it.
View narrativezł293.45
FV
2.2% undervalued intrinsic discount9.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
1users have followed this narrative
1 day ago author updated this narrative
FR
FrugalBull
Community Contributor
Enterprise, AI & Cloud Growth Ahead, Waiting For the Right Price 💸
Catalysts AI Integration (Atlassian Intelligence & Rovo) Atlassian is strongly positioned to leverage AI to increase workforce efficiency, particularly in large enterprises and is actively embedding AI across its product suite. In 2024 it introduced Atlassian Rovo , an AI teammate that uses Atlassian’s “teamwork graph” to help enterprise users find information across their tools and act on insights quickly.
View narrativeUS$204.74
FV
9.5% overvalued intrinsic discount19.00%
Revenue growth p.a.
3users have liked this narrative
0users have commented on this narrative
19users have followed this narrative
1 day ago author updated this narrative
DZ
Dzitkowskik
Community Contributor
XTB's Path to 100–120 PLN by 2028 Amid Market Volatility
1. Current Data Snapshot (as of March 6, 2025) XTB is a Warsaw-based brokerage firm specializing in retail and institutional trading of financial instruments, including CFDs, forex, stocks, and ETFs. Here’s what we can infer from available data up to this point: Stock Price Performance: XTB hit an all-time high of 78.00 PLN on January 21, 2025, with a market cap around 7.89 billion PLN (as per TradingView data).
View narrativezł100.96
FV
36.6% undervalued intrinsic discount15.00%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
9users have followed this narrative
2 days ago author updated this narrative
DA
DailyInvestors
Community Contributor
EV Titan: Finally Slade
The true definition of a "Bullish Signals" is sometimes played out to Truly Be a Bearish Signal. Tesla is one that proves that controlling the media can truly bring any company to where they are.
View narrativeUS$95.00
FV
142.7% overvalued intrinsic discount-9.16%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
2 days ago author updated this narrative
UN
Unike
Community Contributor
The demand for personalized medicine will keep Thermo Fisher Scientific thriving
Catalysts Most Immediate Catalysts (1–2 Years) Resilient Demand for Life Sciences & Diagnostics – TMO is a key supplier for biotech, pharma, and research institutions, ensuring steady demand despite economic cycles. Cost Synergies from PPD Acquisition – The 2021 acquisition of PPD (clinical research services) is expected to enhance revenue synergies and margin expansion.
View narrativeUS$540.27
FV
4.8% undervalued intrinsic discount7.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
2 days ago author updated this narrative
UN
Unike
Community Contributor
Apotea is poised for growth with its online pharmacy dominance and upcoming market expansions
Catalysts Most Immediate Catalysts (1–2 Years) Online Pharmacy Market Growth: The Swedish pharmacy market is shifting online, benefiting Apotea as the dominant e-commerce player. Consumers increasingly prefer digital purchases over physical store visits.
View narrativeSEK 94.41
FV
22.4% undervalued intrinsic discount7.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
3users have followed this narrative
2 days ago author updated this narrative
UN
Unike
Community Contributor
Catena Logistics Will Thrive with E-commerce Growth as Rents Increase
Catalysts Most Immediate Catalysts (1–2 Years) E-commerce Growth Driving Logistics Demand: Catena’s core business—logistics and warehouse properties—is benefiting from structural growth in e-commerce. As retailers optimize supply chains, demand for modern logistics centers remains high.
View narrativeSEK 229.20
FV
80.4% overvalued intrinsic discount8.00%
Revenue growth p.a.
0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
2 days ago author updated this narrative
WH
White_valkyrie
Community Contributor
Greenwich LifeSciences will eye a valued future at $460 a share, with GP2 leading the way.
*DISCLAIMER: *This article is NOT financial advice of any kind, i am NOT a financial adviser, this content should NOT be construed as an offer, recommendation or inducement to buy or sell Greenwich Lifesciences $GLSI stock. Do yor own Due diligence with this type of products before taking from granted any of these opinions.
View narrativeUS$460.00
FV
97.5% undervalued intrinsic discount103.00%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
7users have followed this narrative
2 days ago author updated this narrative